Clinical trials
Phase 3 Lymphoma, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 6 |
| Recruiting | 5 |
| Terminated | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Loxo Oncology, Inc. | 5 |
| Gustave Roussy, Cancer Campus, Grand Paris | 2 |
| Novartis Pharmaceuticals | 2 |
| Acerta Pharma BV | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| BeOne Medicines | 1 |
| Biogen | 1 |
| City of Hope Medical Center | 1 |
| Czech Lymphoma Study Group | 1 |
| French Innovative Leukemia Organisation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 29 |
| Lymphoma, Non-Hodgkin | 13 |
| Lymphoma | 9 |
| Lymphoma, Large B-Cell, Diffuse | 8 |
| Hematologic Diseases | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma, Mantle-Cell | 4 |
| Lymphatic Diseases | 3 |
| Lymphoproliferative Disorders | 3 |
| Burkitt Lymphoma | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.